off label tirzepatide GLP-1 medications are not approved by the Food and Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label How to Wean Off Tirzepatide
Pay in 4 interest-free payments of $6.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19









![Ozempic Pancreatitis Lawsuit [2026 Update]](https://trulaw.com/wp-content/uploads/2024/02/Ozempic-Pancreatitis-Lawsuit-768x384.jpg)
















